로고

  • HOME
  • SITEMAP
  • kOREAN
Home > Product List & R&D Status > R&D Status
NCE Rho X project Anti-cancer agent including new mechanism reduced side effect of Rho B
KAIARI MOST Genome Research Foundation Project
Preclinical
SPC-702 COPD agent
(W-peptide derivative)
Collaboration with POSTECH
Preclinical
SPX-601 Drug comprising medicinal herb extract for prevention and curing arthritis Phase IIa Clinical
SmartFilm® Vultis®
(Sildenafil citrate ODF)
Orally disintegrating film without drinking water (the highest drug load technology in the world) erectile dysfunction Launched May 2012
Artpezil ®
(Donepezil HCI ODF)
Dementia A Domestic Patent Registeration
Aripiprazole ODF Schizophrenia MA completed
Vulteum®(Tadalafil ODF) Erectile dysfunction Launched Sep 2015
SPO-1107 Anti-emetic Formulation Research
SPO-1304 Antiviral Formulation Research
SPO-1405 Obesity Formulation Research
SPO-1401 Anti-emetic Formulation Research
SPO-1406 Overactive bladder Formulation Research
IMD&GEQ Antipyretic-analgesics Compositions for controlled release acetaminophen dosage form Launched
Timerol ER Tab
Remedy for Allergic rhinitis Remedy comprising quick release and controlled release products for allergic rhinitis Launched
Cerizin Tab
Remedy for Hyperlipidemia Extended release type hyperlipidemia Agent with reduced adverse events though the technology for API-release control Launched
Exlip ER Tab
Remedy for Hyperlipidemia combined pharmaceutical formulation / complex drug Development of the remedy that has different mechanisms and actions for hyperlipidemia combined pharmaceutical formulation (expectation for increasing the medical effect and convenience of taking a medicine easily) Formulation Research
Dosage Form Modification Anti-tussive, Mucolytic Agents, and Expectorants syrup First acetylcysteine syrup increasing safety and taking a medicine to ease in Korea Launched
(Sebron Syrup)
branched chain amino acids suppliment First branched chain amino acids oral suspension formula with improved compliance Launched
(Aliver Suspension)